Clariness, a leading global patient recruitment organisation, has partnered with DailyBreath, an asthma app focused on environmental triggers, to bring more trials to patients and further both parties’ understanding of their respiratory symptoms experience.
The DailyBreath app, available via Google Play or in the App Store, provides members (registered users) with data regarding environmental conditions that can impact their asthma, such as pollution, weather and other factors. It also allows members to report symptoms and engage with one another, to share experiences and contribute broadly to an understanding of how environmental factors impact them individually, and collectively, the community, at large.
Through this new partnership, members of DailyBreath will be given access to clinical trials via the app, aligning them with clinical trials supported by Clariness. “We’re dedicated to helping people with asthma breathe easier, and this partnership offers our members a chance to find new treatments which can help them do exactly that,” said Eric Klos, founder and CEO of DailyBreath.
“We’re proud to be expanding our list of technological partnerships, each one brings us one step closer to providing patients with access to new treatments and therapies across the globe,” commented Michael Stadler, co-founder and CEO of Clariness.
In addition to providing more access to clinical trials, Clariness will use the self-reported data associating symptoms with environmental impact to further advance its patient insights. This data, in conjunction with its own Clinlytics and survey insights, will allow Clariness to provide better information to patients, sites and sponsors.
Clariness has been building partnerships with healthtech, healthcare and patient organisations since 2005 to increase clinical trial awareness and participations across the globe. These partnerships act as channels to drive patient referrals and span multiple therapeutic areas, including oncology, dermatology and respiratory to name a few.